Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
Personalized medicine: through the looking glass of functional imagingRaymond J HohlLipids|September 26, 2003
Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesisSusan E Ownby, Raymond J HohlLipids|March 23, 2002
Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cellsSusan E Ownby, Raymond J HohlThe Journal of Pharmacology and Experimental Therapeutics|December 15, 2007
Erythropoietin stimulates cancer cell migration and activates RhoA protein through a mitogen-activated protein kinase/extracellular signal-regulated kinase-dependent mechanismSumaya N Hamadmad, Raymond J HohlJournal of Cellular Biochemistry|April 20, 2011
The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiationMegan M Weivoda, Raymond J HohlCurrent Opinion in Pharmacology|July 24, 2012
Is there a future for prenyltransferase inhibitors in cancer therapy?Sarah A Holstein, Raymond J HohlLeukemia Research|September 11, 2010
Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cellsSarah A Holstein, Raymond J HohlCurrent Cancer Drug Targets|February 16, 2006
Anti-cancer therapy: targeting the mevalonate pathwayKelly M Swanson, Raymond J HohlJournal of Lipid Research|April 3, 2003
Monoterpene regulation of Ras and Ras-related protein expressionSarah A Holstein, Raymond J HohlLipids|September 11, 2004
Isoprenoids: remarkable diversity of form and functionSarah A Holstein, Raymond J HohlPageof 9